Adipose triglyceride lipase and hormone-sensitive lipase protein expression in subcutaneous adipose tissue is decreased after an isoenergetic low-fat high-complex carbohydrate diet in the metabolic syndrome

Metabolism: Clinical and Experimental
A M J van HeesEllen E Blaak

Abstract

The objective was to determine the contribution of dietary fat quantity and composition to lipolysis and lipolytic gene expression in humans in relation to obesity, insulin resistance, and the metabolic syndrome (MetS). Men and women with the MetS were randomly assigned to one of four isoenergetic diets: a high-fat saturated fat diet (n=10), a high-fat monounsaturated fat diet (n=7), and two low-fat high-complex carbohydrate (LFHCC) diets, one supplemented with 1.24 g/day long-chain n-3 PUFA (LFHCC: n=7, LFHCCn-3: n=8). Subcutaneous adipose tissue biopsies were taken before and after the 12-week dietary intervention period. ATGL and HSL mRNA and protein expression was determined. Whole body rate of appearance of free fatty acids (Ra(FFA)) was determined by intravenous infusion of [(2)H(2)]-palmitate in a subgroup of men (n=20). Adipose tissue ATGL and HSL mRNA and protein expression was not affected by alterations in dietary fat composition. Pooled analysis comparing the low- and high-fat diets showed that ATGL and HSL protein expression was significantly reduced after the LFHCC diets (P=.04), irrespective of long-chain n-3 PUFA. Moreover, LFHCC diets lowered fasting insulin, HOMA(IR), and (LDL)-cholesterol concentrations (P≤.0...Continue Reading

References

Sep 21, 2002·Diabetologia·K N Frayn
Dec 25, 2003·The Proceedings of the Nutrition Society·E E Blaak
Dec 30, 2004·Diabetologia·N ViguerieUNKNOWN Nutrient-Gene Interactions in Human Obesity--Implications for Dietary Guideline (NUGENOB) project
Apr 20, 2005·Lancet·Robert H EckelPaul Z Zimmet
Oct 26, 2005·Biochemical Society Transactions·F Karpe, G D Tan
Nov 1, 2006·The Journal of Biological Chemistry·Martina SchweigerRobert Zimmermann
Jan 12, 2007·Biochimica Et Biophysica Acta·Wen-Jun ShenFredric B Kraemer
Mar 16, 2007·The Journal of Clinical Endocrinology and Metabolism·Johan W E JockenEllen E Blaak
Jul 5, 2007·American Journal of Physiology. Endocrinology and Metabolism·Gregory R SteinbergMatthew J Watt
Jul 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Kitt Falk PetersenGerald I Shulman
Sep 4, 2007·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Angela A RivelleseGabriele Riccardi
Feb 12, 2008·Physiology & Behavior·Johan W E Jocken, Ellen E Blaak
Aug 23, 2008·The Biochemical Journal·Matthew J Watt, Gregory R Steinberg
Dec 19, 2009·Lipids in Health and Disease·Hind RayValérie Large
Jan 29, 2010·American Journal of Physiology. Cell Physiology·Mandeep P GaidhuRolando B Ceddia
Feb 4, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·A M J van HeesE E Blaak

❮ Previous
Next ❯

Citations

Jun 5, 2014·Genes & Nutrition·Antonio CamargoJosé López-Miranda
May 8, 2013·The Journal of Nutritional Biochemistry·Patricia Peña-OrihuelaJose Lopez-Miranda
Jan 25, 2019·Molecular Nutrition & Food Research·Chen HouJia Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.